View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
  1. Dashboards
  2. Patents
March 8, 2022

J&J top AI innovator in three months ending January

Yet, research and innovation in AI in the clinical trial operations sector has declined in the last year.

By Data Journalism Team

Johnson & Johnson was the top artificial intelligence (AI) innovator in the clinical trial operations sector in the latest quarter. The company filed 48 AI-related patents in the three months ending January. That was up from 42 over the same period 12 months prior.

It was followed closely by Roche with 42 AI patent applications and then Thermo Fisher Scientific (12 applications), and Bayer (10 applications).

Johnson & Johnson has recently ramped up R&D in AI. It saw growth of 12.5% in related patent applications in the three months ending January compared to the same period in 2020 - the highest percentage growth out of all companies tracked with more than 10 quarterly patents in the clinical trial operations sector.

Free White Paper

AI in Pharma: Patents trends 2021

By
Enter your details to receive the free paper:

Yet, research and innovation in AI in the clinical trial operations sector has declined in the last year.

The most recent figures show that the number of AI related patent applications in the industry stood at 49 in the three months ending January - down from 97 over the same period in 2020.

Figures for patent grants related to AI followed a similar pattern to filings - shrinking from 27 in the three months ending January 2020 to four in the same period in 2021.

The figures are compiled by GlobalData, who track patent filings and grants from official offices around the world. Using textual analysis, as well as official patent classifications, these patents are grouped into key thematic areas, and linked to key companies across various industries.

AI is one of the key areas tracked by GlobalData. It has been identified as being a key disruptive force facing companies in the coming years, and is one of the areas that companies investing resources in now are expected to reap rewards from.

The figures also provide an insight into the largest innovators in the sector.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Key drug pipeline and competitive landscape changes based on the latest clinical activity, sent every Tuesday. Curated analysis and data-driven insights on clinical trials strategy and operations, sent every Thursday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU